Trellus Health plc
Research Trellus Health plc (TRLS) on Bullrun: market cap GBX 51.61M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTRLS
- ExchangeLSE
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyGBX
- Market capGBX 51.61M
- Financial periodFY2024
- RevenueUSD 114.00K
- Revenue growth500.0%
- Net income-USD 7.78M
- Free cash flow-USD 7.86M
- Gross margin100.0%
Valuation Snapshot
latest market cap is GBX 51.61M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | USD 114.00K | -USD 7.78M | -USD 7.86M | 100.0% | -0.05 | USD 4.34M | n/a | USD 11.77M |
| FY2023 | USD 19.00K | -USD 6.34M | -USD 7.63M | 100.0% | -0.04 | USD 12.17M | n/a | USD 19.50M |
| FY2022 | USD 18.00K | -USD 8.81M | -USD 11.53M | 100.0% | -0.05 | USD 19.09M | n/a | USD 25.09M |
| FY2021 | USD 25.00K | -USD 5.90M | -USD 8.49M | 100.0% | -0.04 | USD 31.98M | n/a | USD 35.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | GBX 51.61M | n/a | n/a | n/a |
About Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Trellus Health plc's market cap?
Trellus Health plc's market capitalization is GBX 51.61M.
What does Trellus Health plc do?
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.